OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alterations in neurotransmitter co-release in Parkinson's disease
Kelsey Barcomb, Christopher Ford
Experimental Neurology (2023) Vol. 370, pp. 114562-114562
Open Access | Times Cited: 15
Kelsey Barcomb, Christopher Ford
Experimental Neurology (2023) Vol. 370, pp. 114562-114562
Open Access | Times Cited: 15
Showing 15 citing articles:
Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compacta
William S. Conrad, Lucie Oriol, Grace J. Kollman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 12
William S. Conrad, Lucie Oriol, Grace J. Kollman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 12
Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 4
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 4
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2025)
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2025)
Open Access
Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2025) Vol. 12
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2025) Vol. 12
Open Access
Imaging Probes for the Detection of Brain Microenvironment
Shiming Zhang, Tianyu Wang, Tianzi Gao, et al.
Colloids and Surfaces B Biointerfaces (2025), pp. 114677-114677
Closed Access
Shiming Zhang, Tianyu Wang, Tianzi Gao, et al.
Colloids and Surfaces B Biointerfaces (2025), pp. 114677-114677
Closed Access
Real-Time Monitoring of Tyrosine Hydroxylase Activity with a Ratiometric Fluorescent Probe
Jiayi Yao, Lü Li, Ji‐Xuan Xu, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 18, pp. 7082-7090
Closed Access | Times Cited: 4
Jiayi Yao, Lü Li, Ji‐Xuan Xu, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 18, pp. 7082-7090
Closed Access | Times Cited: 4
Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compacta
William S. Conrad, Lucie Oriol, Grace J. Kollman, et al.
Addiction Neuroscience (2024) Vol. 13, pp. 100183-100183
Open Access | Times Cited: 3
William S. Conrad, Lucie Oriol, Grace J. Kollman, et al.
Addiction Neuroscience (2024) Vol. 13, pp. 100183-100183
Open Access | Times Cited: 3
6-Hydroxydopamine-induced decrease in dopaminergic neurons is avoided by effusol and dehydroeffusol, unique phenanthrenes of Juncus effusus
Misa Katahira, Haruna Tamano, Toshiyuki Fukuda, et al.
PharmaNutrition (2024) Vol. 29, pp. 100403-100403
Closed Access | Times Cited: 1
Misa Katahira, Haruna Tamano, Toshiyuki Fukuda, et al.
PharmaNutrition (2024) Vol. 29, pp. 100403-100403
Closed Access | Times Cited: 1
Neurotoxicology of dopamine: Victim or assailant?
Meghan L. Bucher, Jocelyn Dicent, Carolina Duarte Hospital, et al.
NeuroToxicology (2024) Vol. 103, pp. 175-188
Closed Access
Meghan L. Bucher, Jocelyn Dicent, Carolina Duarte Hospital, et al.
NeuroToxicology (2024) Vol. 103, pp. 175-188
Closed Access
Unveiling MRI markers for Parkinson’s Disease: GABAergic dysfunction and cortical changes
Yuan Tian, Sijia Geng, Tianyi Liu, et al.
NeuroImage Clinical (2024) Vol. 43, pp. 103661-103661
Open Access
Yuan Tian, Sijia Geng, Tianyi Liu, et al.
NeuroImage Clinical (2024) Vol. 43, pp. 103661-103661
Open Access
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2024)
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2024)
Open Access
Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson’s disease: an atlas-based correlation analysis
Huize Pang, Xiaolu Li, Ziyang Yu, et al.
Cerebral Cortex (2024) Vol. 34, Iss. 10
Closed Access
Huize Pang, Xiaolu Li, Ziyang Yu, et al.
Cerebral Cortex (2024) Vol. 34, Iss. 10
Closed Access
Editorial: Intersection of neural activity, synuclein and Parkinson's disease
Ken Nakamura
Experimental Neurology (2024), pp. 115091-115091
Closed Access
Ken Nakamura
Experimental Neurology (2024), pp. 115091-115091
Closed Access
The kinase LRRK2 is required for the physiological function and expression of the glial glutamate transporter EAAT2 (SLC1A2 )
Angela Di Iacovo, Chiara d’Agostino, Manan Bhatt, et al.
Journal of Neurochemistry (2024) Vol. 169, Iss. 1
Open Access
Angela Di Iacovo, Chiara d’Agostino, Manan Bhatt, et al.
Journal of Neurochemistry (2024) Vol. 169, Iss. 1
Open Access
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2023)
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2023)
Open Access
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
